ATE511643T1 - Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer - Google Patents
Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimerInfo
- Publication number
- ATE511643T1 ATE511643T1 AT06784840T AT06784840T ATE511643T1 AT E511643 T1 ATE511643 T1 AT E511643T1 AT 06784840 T AT06784840 T AT 06784840T AT 06784840 T AT06784840 T AT 06784840T AT E511643 T1 ATE511643 T1 AT E511643T1
- Authority
- AT
- Austria
- Prior art keywords
- alzheimer
- disease
- neurosecretoric
- biomarrker
- fragment
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102100037571 Neurosecretory protein VGF Human genes 0.000 abstract 1
- 101710176810 Neurosecretory protein VGF Proteins 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 238000004949 mass spectrometry Methods 0.000 abstract 1
- 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69163705P | 2005-06-16 | 2005-06-16 | |
| PCT/US2006/023044 WO2006138325A2 (en) | 2005-06-16 | 2006-06-13 | Fragment of neurosecretory protein vgf as a biomarker for alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511643T1 true ATE511643T1 (de) | 2011-06-15 |
Family
ID=37571081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06784840T ATE511643T1 (de) | 2005-06-16 | 2006-06-13 | Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1907838B1 (de) |
| JP (1) | JP2008547003A (de) |
| AT (1) | ATE511643T1 (de) |
| WO (1) | WO2006138325A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11360098B2 (en) * | 2015-09-28 | 2022-06-14 | Quest Diagnostics Investments Llc | Amyloid beta detection by mass spectrometry |
| FR3160503A1 (fr) | 2024-03-19 | 2025-09-26 | M&Wine | Procédé et dispositif de diagnostic, pronostic et/ou de suivi thérapeutique de maladies impactant le profil minéral d’au moins un fluide biologique. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6283761B1 (en) * | 1992-09-08 | 2001-09-04 | Raymond Anthony Joao | Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information |
| NZ516848A (en) * | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
| DE10291524D2 (de) | 2001-04-06 | 2004-07-01 | Anker Thorsten | Verfahren zum Nachweis chronisch-demenzieller Erkrankungen, zugehörige Peptide und Nachweisreagenzien |
| CA2746000C (en) * | 2002-08-23 | 2014-10-21 | Bayer Schering Pharma Aktiengesellschaft | Biomarkers for diagnosing alzheimer's disease |
| US7794948B2 (en) | 2003-11-07 | 2010-09-14 | Vermilllion, Inc. | Biomarkers for alzheimer's disease |
-
2006
- 2006-06-13 AT AT06784840T patent/ATE511643T1/de not_active IP Right Cessation
- 2006-06-13 EP EP06784840A patent/EP1907838B1/de not_active Not-in-force
- 2006-06-13 WO PCT/US2006/023044 patent/WO2006138325A2/en not_active Ceased
- 2006-06-13 JP JP2008517032A patent/JP2008547003A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| HK1110388A1 (en) | 2008-07-11 |
| EP1907838A2 (de) | 2008-04-09 |
| EP1907838B1 (de) | 2011-06-01 |
| JP2008547003A (ja) | 2008-12-25 |
| WO2006138325A3 (en) | 2007-05-31 |
| EP1907838A4 (de) | 2008-10-01 |
| WO2006138325A2 (en) | 2006-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700136A1 (ru) | Анти-cd154-антитела | |
| ATE497508T1 (de) | Gegen das säugetier-eag1-ionenkanalprotein gerichtete antikörper | |
| WO2007133623A3 (en) | Peptide diagnostic agent for lyme disease | |
| NO20072721L (no) | Polypeptides that bind BR3 and uses thereof | |
| ATE495447T1 (de) | Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie | |
| UA96139C2 (uk) | Антитіло до нейропіліну-1 (nrp1) | |
| WO2007007192A8 (en) | Use of ionic matrices for maldi mass spectrometry analysis of tissue sections | |
| DK1571970T3 (da) | Diagnose og monitorering af sygdomme | |
| WO2007062090A3 (en) | Methods and compositions related to b cell assays | |
| BRPI0506771A (pt) | anticorpo, e, composição farmacêutica | |
| BRPI0507856A (pt) | composição farmacêutica, e, processo para preparar o anticorpo abeta | |
| BRPI0520677A2 (pt) | identificação e caracterização de anticorpos de função de bloqueio anti-ed-b-fibronectina | |
| WO2006086799A3 (en) | Prion-specific peptide reagents | |
| DE60133661D1 (de) | Nachweismittel von patologischen veränderungen des proteins app und ihre verwendungen | |
| EA200702193A1 (ru) | Гликозилирование белков | |
| WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum | |
| BRPI0607692A2 (pt) | peptìdeos para detecção de anticorpo para o vìrus da sìndrome reprodutiva e respiratória suìna | |
| DE60219645D1 (de) | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft | |
| DE602006018424D1 (de) | Peptide zum nachweis von ehrlichia ewingii antikörper | |
| ATE511643T1 (de) | Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer | |
| ATE520025T1 (de) | Test für morbus-parkinson-therapeutika | |
| SI1745295T1 (sl) | Metode, sestavljanje in preizkuĺ anje spojine za zaviranje tvorbe proteina amiloid-beta | |
| DE602006013143D1 (de) | Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate | |
| RU2010126590A (ru) | Новые аллергены пшеницы | |
| ATE525478T1 (de) | Serumbiomarker für morbus chagas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |